MYL News and Press, Mylan N.V. From 07/07/20

HERTFORDSHIRE, England and PITTSBURGH , July 7, 2020 /PRNewswire/ -- Mylan N.V.  (NASDAQ: MYL) today announced that its U.S.-based Mylan Institutional LLC business is conducting a voluntary nationwide recall to the consumer level of one lot of Daptomycin for Injection, 500 mg/vial...

Gilead Sciences (NASDAQ: GILD ) licensee Mylan N.V. (NASDAQ: MYL ) announces that the Drug Controller General of India has approved its remdesivir 100 mg/vial for restricted emergency use for severely ill hospitalized pediatric and adult COVID-19 patients. More news on: Mylan, Inc., Gile...

HERTFORDSHIRE, England and PITTSBURGH and BANGALORE, India , July 6, 2020 /PRNewswire/ -- Mylan N.V. (NASDAQ: MYL) today announced that the Drug Controller General of India (DCGI) has approved its remdesivir 100 mg/vial for restricted emergency use in Indi...

HERTFORDSHIRE, England and PITTSBURGH , June 30, 2020 /PRNewswire/ -- Mylan N.V. (Nasdaq: MYL) today announced that its shareholders overwhelmingly voted to approve the proposed transaction combining Mylan and Upjohn, a division of Pfizer, at the company's extraordinary general mee...

People are living longer and longer lives these days, but sadly, that also means more people are living with -- and dying from -- Alzheimer's disease (AD), which is marked by a serious decline in mental ability. According to the Alzheimer's Association, there are more than 5 million people in th...

Pfizer, Inc. ( PFE ) is undergoing a massive transformation over the past two years driven by the new CEO. Once complete it will be a whole new ballgame for Pfizer. The company will be focused on research & development for prescription medicines. It will only be involved with consumer heal...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Using stock screeners to filter out stocks that are trading at low price-to-earnings (P/E) or price-to-book (P/B) multiples can be a way to uncover some cheap investments. But some stocks are destined to stay at low multiples because they're risky or offer little to no growth. One biotech stock...

Pfizer ( PFE ) has agreed with Mylan ( MYL ) to separate its generic drug business Upjohn and combine it with MYL to form a new company named Viatris. Viatris will be listed as an independent company going forward. The deal is expected to complete in the immediate next quarter. As part of the ...

Reuters is reporting biopharma giant Sanofi (NASDAQ: SNY) will discuss job cuts with staff representatives tomorrow and Monday that could reduce its headcount by up to 1,000 people. The possible reorganization is part of plans announced in December to eliminate $2.24 billion in spending ...